Latest total liabilities for SOLARA.NS: $10B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Solara Active Pharma Sciences Limited posts a total liabilities of $10B as of September 2026. That compares with $10B in the prior-year period — down 2.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Solara Active Pharma Sciences Limited's total liabilities was $10B. The latest reading is $10B — a 2.0% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.
Total Liabilities is one piece of Solara Active Pharma Sciences Limited's financial statement story. At $10B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for SOLARA.NS's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Solara Active Pharma Sciences Limited's other metric pages and overview cover the third.